Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.78B P/E - EPS this Y 29.10% Ern Qtrly Grth -
Income -449.64M Forward P/E -4.75 EPS next Y 46.30% 50D Avg Chg -9.00%
Sales 1.9M PEG 0.41 EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book 2.42 EPS next 5Y -19.00% 52W High Chg -46.00%
Recommedations 1.90 Quick Ratio 4.28 Shares Outstanding 279.83M 52W Low Chg 36.00%
Insider Own 0.54% ROA -34.48% Shares Float 207.36M Beta 0.65
Inst Own 89.46% ROE -66.77% Shares Shorted/Prior 50.06M/46.38M Price 7.18
Gross Margin - Profit Margin - Avg. Volume 6,016,856 Target Price 25.92
Oper. Margin -16,464.62% Earnings Date Aug 6 Volume 4,421,887 Change -0.14%
About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.

Iovance Biotherapeutics, Inc. News
05/17/24 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
05/16/24 4 Small-Cap Value Stocks That Could Go Parabolic
05/11/24 The 3 Most Undervalued Biotech Stocks to Buy in May 2024
05/10/24 Why Iovance Stock Is Down 18% Today
05/10/24 Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
05/10/24 Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
05/10/24 Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
05/10/24 Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
05/09/24 Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
05/06/24 Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
05/06/24 Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
05/01/24 Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
04/30/24 Iovance Biotherapeutics to Present at Upcoming Conferences
04/29/24 With 63% ownership of the shares, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is heavily dominated by institutional owners
04/28/24 Where Will Iovance Biotherapeutics Stock Be in 5 Years?
04/27/24 The Top 3 Biotech Stocks to Buy in April 2024
04/25/24 3 Millionaire-Maker Biotech Stocks
04/25/24 20 Counties with the Highest Cancer Rates in the US
04/24/24 Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
04/21/24 These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
IOVA Chatroom

User Image User123321 Posted - 2 hours ago

$IOVA Finviz still depicts this as a triangle chart pattern after it broke down 6 sessions ago. Taking out fundamental news this will likely see a reversal at some point which could be soon to very soon. An intraday breach and/or bounce off 200 EMA at 10.02 is quite possible. Levels below there: 50 week EMA 9.71 ( eh, not much of a level but something ), the non gap closing price of 9.15 and the 61.8% retrace level of 8.99 ( 3.21-18.33 low to high 52 week range). $9 area makes sense but will it even get that low? Lower? I wouldn’t think so but we’ll see. Obviously if things work out well $10 or $9 or less than $9 won’t matter. Good luck longs. 😀👍

User Image tmantrade Posted - 3 hours ago

$IOVA https://www.youtube.com/watch?v=rFzc1DQxl1c&ab_channel=MoneyPigTrading

User Image Hounddoggie Posted - 4 hours ago

$IOVA https://youtu.be/rFzc1DQxl1c?si=eneNM4QGKog_mSL_

User Image Iceerrr Posted - 5 hours ago

$IOVA feel like things have been going on at the negotiating table for longer then we think already. Maybe BP moment to act was right as they got approval. I mean it’s already been 3 months since approval. Negotiating might be coming to a close soon.

User Image BioAmerica Posted - 5 hours ago

$IOVA There are too many examples like that to list here. My favorite is IMMU. They walked it all the way down to the mid-single digits. Then it started a run, based around $40, and GILD bought it out for $21B ($88/share). All within less than 9 months. Let them play their games. I just add more when I think it is too low. And it is not just here. Most of my 15 small bios have the same problem. The whole sector can't be junk.

User Image Gettingtillywithit Posted - 5 hours ago

$IOVA BAMIN: I read biotechmd on X entire post I think even dolt like me can see through the din that we are headed to gold

User Image burger6587 Posted - 5 hours ago

$IOVA I owned tril in 2020. It went from $2 to $20 by Dec. They walked it down to $6 by Aug of 21 and pfe bought it for $17.50 in Oct.

User Image Yorko2020 Posted - 6 hours ago

$IOVA I will agree all the negative Nellie’s and the falling stock price has gotten to me. I’m not selling a share however. Once I do a BO will occur. Now, if it does get to my average I will sell and buy again. I don’t anticipate that happening but I am not going through that again. I was 40k or 50k down when it went to 3. I am shocked that we are getting facked like this again. I promise you all I will not do another bio so you can be rid of me after this! I do have hope that asco will make us rise. ☹️❤️

User Image Hounddoggie Posted - 8 hours ago

$IOVA And the latest analyst targets...

User Image Hounddoggie Posted - 8 hours ago

$IOVA "Pepper" Blocked.

User Image day_um Posted - 8 hours ago

$IOVA G'mornin'

User Image Tropicalbeachtrader Posted - 10 hours ago

$IOVA I dont understand why the short volume was so high right after we got the FDA approval, but since then it has been fallen a bit. I cannot see the reason why we should not be in the 20s in august. The time to cover is also around the corner. Lets have some green candlesticks next week 👌🏼 https://www.marketbeat.com/stocks/NASDAQ/IOVA/short-interest/

User Image WheresMuhMoney Posted - 14 hours ago

$IOVA Long. No stops, no sells… stop being such weak ass MFers. Lonnnnnnnng haul! My $7 buys felt terrible when we went to $3. Your $16 buys may feel horrible at $10 as well but what happened when we went to $3? All these shorts can suck a mean one…

User Image ILUVSPEWINGNONSENSE Posted - 14 hours ago

$IOVA I for one AM NOT QUESTIONING MY INVESTMENT...YOU PEOPLE ARE WEAK! I'm sorry but it's only PSYCHOLOGICAL so STFU!!! THERE'S ABSOLUTELY NOTHING WRONG!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! I Think this site is actually making me dumber than I already am? 🤪 and that's pretty fucking difficult I might add! 😂

User Image Night_Owl_Biotech Posted - 15 hours ago

The attachment notes the enterprise values paid KDMN, RETA & PRVB as multiples of the revenue forecasts prepared by the acquiree's management. All 3 were acquired within 2-5 months of FDA approval. At the bottom you'll see $MDGL enterprise value as multiples of analyst consensus revenue estimates per Seeking Alpha. Rezdiffra was approved 2 months ago. We have no idea if MDGL is about to be acquired, but you can see the upside if MDGL is acquired at multiples consistent with these peers. A reminder, enterprise value is different than market cap (upside is not necessarily proportional). $DAWN $SWTX $IOVA & $XFOR also have recent approvals

User Image calbucs Posted - 15 hours ago

$IOVA blocked that DA

User Image calbucs Posted - 15 hours ago

$IOVA these paid per post hoes are coming from everywhere to create doubt and fear on an approved melanoma cancer drug . Pathetic ! Trash / Blocked

User Image TriGuy8542 Posted - 15 hours ago

$IOVA idk who needs to hear this but… Wall Street set up the FUD They knew last Q would come in light and management can’t release forecasts so they short he stock down They spread FUD to get cheap shares Next Q real revenue through the door and the stock will shoot up and all will be resolved. Happens like clockwork

User Image Iceerrr Posted - 15 hours ago

$IOVA what’s happening is making every one of us question our investment. Let me ask you guys something? This price doesn’t make sense to not one of us. So I think it’s obvious something’s up. Dropping the price to before approval is crazy. Makes 0 sense. The only like actually logic for a dip like that is dilution or an fda decline.

User Image Insight4u2004 Posted - 16 hours ago

$IOVA SO MUCH FUD here! It’s by design so retail coughs up their shares!! Don’t be FOOLED! It’s a company with a novel approach to beating back cancer AND its BIG BUSINESS!! Big PHARMA is watching and will move in at the right time and price!! EMBRACE the discounting and ADD MORE when and where appropriate…

User Image Pepper214 Posted - 17 hours ago

$IOVA So now people are hoping for 7 to buy more....take a lookar options trading someone bought 7.5 and 5 strike puts last week....Also on Friday someone SOLD 500 of the January 10 strike calls at 3.05 with bid 3 ask 3.30...That suggests they are protecting down to 6.95....There is very little options premium out to 2026....Nothing makes sense because we are so optimistic and Company has not been clear with any revenue patient or reimbursements data...So here are the 3 material issues for which the Company hasnot been transparent 1. What is the reimbursement rate so far on approved and processed claims 2. How many have been approved 3. How much is the cost to build out the centers 4. How much are we burning now with the expansion 5.What is our true cash position through 2025

User Image Pepper214 Posted - 17 hours ago

$IOVA We have declined from18.33 down to 10.11 and heading lower...Everyone says WR is in control so please explain how he wanted his investment to drop 240M....There are always leaks and someone in company knows that this start up of 70 centers actually costs more than anticipated. Reimbursements take longer if you look at your explanation of benefits if you have had chemo. I'm with the 2nd largest insurer and my Feb treatments are just getting paid...The relentless shorts have some data that supports their behavior. Everyone has said we will be bought at 50 or 60 but that is only hope. On the 2nd or 3rd Fireside chat it was mentioned that we had enough cash till 1st half 25 so I wrote to IR and they said 2nd half..Maybe she was protecting the truth...Something is just no longer making sense

User Image burger6587 Posted - 19 hours ago

$IOVA I have a bunch at $12.50. $7 would be a great buying opportunity. I do not think it gets there, but I am not a chartist.

User Image burger6587 Posted - 20 hours ago

$IOVA $7 would be a nice entry $.

User Image TopCharts Posted - 20 hours ago

$IOVA $7-9 range soon based on charts

User Image FE123 Posted - 21 hours ago

$IOVA Where is the Bottom Chart People?

User Image R_NW Posted - 22 hours ago

$IOVA Just waiting for a sign the bottom has been reached and then will start adding ahead of Q2 ER.

User Image GriZlyBeAr Posted - 22 hours ago

$IOVA

User Image Gettingtillywithit Posted - 23 hours ago

$IOVA pretty good piece: https://nz.news.yahoo.com/finance/news/iovance-iova-updates-combo-drug-123900365.html

User Image Gettingtillywithit Posted - 23 hours ago

$IOVA BAMIN: a question please. Is this biotechmd on X making claims AGAINST IOVA? The Chinese arithmetic you guys throw out I dont follow so I cant tell it seems as if you are confronting his assertions. Is that correct?

Analyst Ratings
HC Wainwright & Co. Buy May 10, 24
Piper Sandler Overweight Mar 14, 24
Truist Securities Buy Mar 7, 24
HC Wainwright & Co. Buy Mar 4, 24
Wells Fargo Overweight Mar 1, 24
HC Wainwright & Co. Buy Feb 29, 24
Goldman Sachs Buy Feb 29, 24
Barclays Overweight Feb 29, 24
Goldman Sachs Buy Feb 21, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rothbaum Wayne P. Director Director Sep 15 Buy 5.3 5,000,000 26,500,000 23,067,333 09/15/23
Rothbaum Wayne P. Director Director Dec 02 Buy 6.50 10,000,000 65,000,000 18,067,333 12/02/22
Vogt Frederick G Interim CEO & Genera.. Interim CEO & General Counsel Nov 28 Buy 5.98 1,000 5,980 2,000 11/28/22
MCPEAK MERRILL A Director Director Nov 28 Buy 6.18 10,000 61,800 228,633 11/28/22
Dukes Iain D. Director Director Nov 23 Buy 6.10 10,000 61,000 22,000 11/28/22
MCPEAK MERRILL A Director Director May 31 Buy 6.82 20,000 136,400 218,633 06/02/22
Maynard Ryan D Director Director May 31 Buy 6.745 7,500 50,588 7,500 06/02/22
WEISER MICHAEL Director Director May 31 Buy 6.8 10,000 68,000 112,632 06/02/22
Vogt Frederick G Interim CEO & Genera.. Interim CEO & General Counsel Jun 01 Buy 6.44 1,000 6,440 1,000 06/02/22
Rothbaum Wayne P. Director Director May 31 Buy 6.6 1,000,000 6,600,000 8,067,333 06/02/22